1. 90Y‐IBRITUMOMAB TIUXETAN IN PATIENTS WITH EXTRA‐NODAL MARGINAL ZONE B‐CELL LYMPHOMA OF MUCOSA ASSOCIATED LYMPHOID TISSUE (MALT LYMPHOMA) – THE ZENO STUDY. (12th June 2019) Authors: Marangon, M.; Morigi, A.; Casadei, B.; Broccoli, A.; Nanni, L.; Stefoni, V.; Argnani, L.; Lolli, G.; Carella, M.; Zinzani, P. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 263 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FIL‐PTCL13: PHASE IB/II STUDY OF ROMIDEPSIN/CHOEP FOLLOWED BY HIGH‐DOSE CHEMOTHERAPY AND TRANSPLANTATION IN UNTREATED PERIPHERAL T‐CELL LYMPHOMAS. (June 2017) Authors: Chiappella, A.; Carniti, C.; Ceccarelli, M.; Cabras, M.G.; Re, A.; Salvi, F.; Santoro, A.; Stefoni, V.; Pileri, S.; Ciccone, G.; Corradini, P. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 426 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FIRST SALVAGE TREATMENT WITH BENDAMUSTINE AND BRENTUXIMAB VEDOTIN IN HODGKIN LYMPHOMA: A PHASE 2 STUDY OF FIL ONLUS. (12th June 2019) Authors: Stefoni, V.; Broccoli, A.; Botto, B.; Corradini, P.; Pinto, A.; Re, A.; Vitolo, U.; Fanti, S.; Argnani, L.; Zinzani, P. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 296 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. HISTOLOGICAL VERIFICATION OF POSITIVE POSITRON EMISSION TOMOGRAPHY FINDINGS DURING THE FOLLOW‐UP OF PATIENTS WITH MEDIASTINAL LYMPHOMA: LARGE EXPERIENCE ON 96 PATIENTS. (June 2017) Authors: Quirini, F.; Forti Parri, S.; Tonialini, L.; Stefoni, V.; Broccoli, A.; Pellegrini, C.; Marangon, M.; Bonfanti, B.; Argnani, L.; Zinzani, P. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 167 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. KMT2D AND TP53 MUTATIONS PREDICT POOR PFS AND OS IN MANTLE CELL LYMPHOMA RECEIVING HIGH‐DOSE THERAPY AND ASCT: THE FONDAZIONE ITALIANA LINFOMI (FIL) MCL0208 PHASE III TRIAL. (June 2017) Authors: Ferrero, S.; Rossi, D.; Bruscaggin, A.; Evangelista, A.; Di Rocco, A.; Spina, V.; Stefoni, V.; Ghione, P.; Barbero, D.; Monitillo, L.; Gomes Da Silva, M.; Santoro, A.; Molinari, A.; Ferreri, A.; Piccin, A.; Cortelazzo, S.; Ladetto, M.; Gaidano, G. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PHASE II FIL‐PTCL13 STUDY OF ROMIDEPSIN‐CHOEP FOLLOWED BY HIGH‐DOSE CHEMOTHERAPY AND TRANSPLANTATION IN UNTREATED PERIPHERAL T‐CELL LYMPHOMAS. (12th June 2019) Authors: Chiappella, A.; Carniti, C.; Evangelista, A.; Re, A.; Cabras, M.G.; Stefoni, V.; Castellino, C.; Congiu, A.G.; Pinto, A.; Zanni, M.; Rusconi, C.; Molinari, A.L.; Ciancia, R.; Baldini, L.; Nassi, L.; Re, F.; Tani, M.; Ilariucci, F.; Cavallo, F.; Santoro, A. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 557 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗